← Open Payments lookup

DANICHI YOSHIDA: Open Payments

NPI 1679971352 · NEWPORT BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,198 in 157 payments from 20 companies in 2025. Trend: 2023 $3,728 · 2024 $4,142 · 2025 $4,198

Food & beverage: $4,183Travel & lodging: $15
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.17$634
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)25$611
Neurocrine BioSciences, Inc.16$593
Otsuka America Pharmaceutical, Inc.11$381
Alkermes, Inc.15$258
Janssen Pharmaceuticals, Inc8$239
Axsome Therapeutics, Inc.10$233
E.R. Squibb & Sons, L.L.C.5$212
Lundbeck LLC10$211
Teva Pharmaceuticals USA, Inc.8$169

Products named: CAPLYTA, INGREZZA, HETLIOZ, REXULTI, SPRAVATO, Auvelity, FANAPT, ABILIFY ASIMTUFII.

Industry payments across CA — which companies pay providers there.